Prevention of myocardial infarction

Internal Medicine Journal

Volumn 32, Issue 12, 2002, Pages 595-600

  Adams, Mark R ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Coronary artery disease; Myocardial infarction

Indexed keywords

CARDIOVASCULAR RISK; CAUSE OF DEATH; CORONARY ARTERY DISEASE; DEVELOPING COUNTRY; HEALTH CARE ACCESS; HEALTH CARE COST; HEART INFARCTION; HEART INFARCTION PREVENTION; HIGH RISK PATIENT; HUMAN; INFLAMMATION; LIFESTYLE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; ARTERIOSCLEROSIS; ARTICLE; COMORBIDITY; DIABETIC ANGIOPATHY; ENDOSCOPIC ECHOGRAPHY; RISK FACTOR;

ARTERIOSCLEROSIS; COMORBIDITY; DIABETIC ANGIOPATHIES; HUMANS; LIFE STYLE; MYOCARDIAL INFARCTION; RISK ASSESSMENT; RISK FACTORS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 0036982538     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1445-5994.2002.00301.x     Document Type: Review

References (25)

1. Faxon D, Lenfant C. Timing is everything: motivating patients to call 9-1-1 at onset of acute myocardial infarction. Circulation 2001; 104: 1210-1.
2. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001; 104: 365-72.
3. Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D. Serum cholesterol, blood pressure and mortality: implications from a cohort of 361,662 men. Lancet 1986; ii: 933-6.
4. Pocock SJ, McCormack V, Gueyffier F, Boutitie F, Fagard RH, Boissel JP. A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials. Br Med J 2001; 323: 75-81.
5. National Heart Foundation of Australia. Lipid Management Guidelines - 2001. Canberra: National Heart Foundation of Australia; 2001.
6. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001; 285: 2486-97.
7. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-43.
8. Fishbein MC, Siegel RJ. How big are coronary atherosclerotic plaques that rupture? Circulation 1996; 94: 2662-6.
9. Nissen SE, Yock P. Intravascular ultrasound: novel pathophysiological insights and current clinical applications. Circulation 2001; 103: 604-16.
10. Stefanadis C, Toutouzas K, Tsiamis E, Vavuranakis M, Kallikazaros I, Toutouzas P. Thermography of human arterial system by means of new thermography catheters. Cathet Cardiovasc Interven 2001; 54: 51-8.
11. Nieman K, Oudkerk M, Rensing BJ, van Ooijen P, Munne A, van Geuns RJ et al. Coronary angiography with multi-slice computed tomography. Lancet 2001; 357: 599-603.
12. Detrano RC, Wong ND, Doherty TM, Shavelle RM, Tang W, Ginzton LE et al. Coronary calcium does not accurately predict near-term future coronary events in high-risk adults. Circulation 1999; 99: 2633-8.
13. Fayad ZA, Fuster V. Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. Circulation Res 2001; 89: 305-16.
14. Beckman JA, Ganz J, Creager MA, Ganz P, Kinlay S. Relationship of clinical presentation and calcification of culprit coronary artery stenoses. Arteriosclerosis, Thrombosis Vascular Biol 2001; 21: 1618-22.
15. Kim WY, Danias PG, Stuber M, Flamm SD, Plein S, Nagel E. et al. Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med 2001; 345: 1863-9.
16. Adams MR, Celermajer DS. Detection of presymptomatic atherosclerosis: a current perspective. Clin Sci 1999; 97: 615-24.
17. Schachinger V, Zeiher AM. Prognostic implications of endothelial dysfunction: does it mean anything? Coronary Artery Dis 2001; 12: 435-43.
18. Fuster V, Gotto AM Jr. Risk reduction. Circulation 2000; 102: IV94-IV102.
19. Tice JA, Ross E, Coxson PG, Rosenberg I, Weinstein MC, Hunink MG et al. Cost-effectiveness of vitamin therapy to lower plasma homocysteine levels for the prevention of coronary heart disease: effect of grain fortification and beyond. JAMA 2001; 286: 936-43.
20. Sesso HD, Paffenbarger RS Jr, Lee IM. Physical activity and coronary heart disease in men: the Harvard Alumni Health Study. Circulation 2000; 102: 975-80.
21. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/Texcaps. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 1998; 279: 1615-22.
22. Fox R. Statins: the new aspirin? Circulation 2001; 104: e9051-e9052.
23. Haq IU, Ramsay LE, Wallis EJ, Isles CG, Ritchie LD, Jackson PR. Population implications of lipid lowering for prevention of coronary heart disease: data from the 1995 Scottish health survey. Heart 2001; 86: 289-95.
24. Cook NR, Herbert PR, Manson JE, Buring JE, Hennekens CH. Self-selected posttrial aspirin use and subsequent cardiovascular disease and mortality in the physicians' health study. Arch Intern Med 2000; 160: 921-8.
25. Chaturvedi N. HOPE and extension of the indications for ACE inhibitors: heart outcomes prevention evaluation. Lancet 2000; 355: 246-7.